Laxai Pharma Ltd (LAXAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2 | 2 | 4 | 9 | 2 |
| Receivables | 0 | 0 | 0 | 0 | 20 |
| Other current assets | 0 | 0 | 0 | 21 | -2 |
| TOTAL | $2 | $2 | $4 | $30 | $20 |
| Non-Current Assets | |||||
| Investments And Advances | 20 | 0 | 80 | 0 | 140 |
| TOTAL | $20 | $N/A | $80 | $N/A | $140 |
| Total Assets | $20 | $20 | $90 | $160 | $170 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 230 | 220 | 210 | 180 | 0 |
| Accrued Expenses | 0 | 0 | 0 | 5 | 5 |
| Other current liabilities | 910 | 10 | 10 | 0 | 0 |
| TOTAL | $1,150 | $1,130 | $1,030 | $190 | $180 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 0 | 720 | 490 |
| TOTAL | $N/A | $N/A | $N/A | $720 | $490 |
| Total Liabilities | $1,150 | $1,130 | $1,030 | $910 | $670 |
| Shareholders' Equity | |||||
| Common Shares | 440 | 440 | 440 | 440 | 440 |
| Retained earnings | -4,230 | -4,210 | -4,050 | -3,810 | -3,520 |
| Other shareholders' equity | 10 | 10 | 10 | 0 | 10 |
| TOTAL | $-1,120 | $-1,100 | $-940 | $-750 | $-500 |
| Total Liabilities And Equity | $30 | $30 | $90 | $160 | $170 |